We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BOSTON SCIENTIFIC CLEARED TO BEGIN LIBERTE TRIAL
BOSTON SCIENTIFIC CLEARED TO BEGIN LIBERTE TRIAL
July 23, 2004
Boston Scientific did receive some positive news last week, as the FDA approved the firm’s investigational device exemption (IDE) filing to initiate the U.S. trial of its next-generation drug-eluting stent (DES) system, the Taxus Liberte.